Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors.
Nira Hernández-MartínDepartment of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut.
Tutukhanim BalayevaDepartment of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut.
Mika NaganawaDepartment of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut.
Ruth H AschDepartment of Psychiatry, Yale School of Medicine, New Haven, Connecticut.
Yiyun HuangDepartment of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut.
Richard E CarsonDepartment of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut.
Jean-Dominique GallezotDepartment of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut.
Zhengxin CaiDepartment of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut; jason.cai@yale.edu.
Funding
YALE UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD PROGRAMUL1RR024139 · NCRR · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2006 to 2011
$56.8M
Validation of Fluorine-18 radioligand for PET imaging of synaptic density in Alzheimer's diseaseR01AG065474 · NIA · YALE UNIVERSITY · PI HUANG, YIYUN HENRY, VAN DYCK, CHRISTOPHER H · 2020 to 2024
$3.9M
SV2A PET in Spinal Cord Injury ImagingR01NS123183 · NINDS · YALE UNIVERSITY · PI Zhengxin Cai · 2022 to 2026
$3.3M
PET Imaging of Synaptic Density in Alzheimers DiseaseR01AG052560 · NIA · YALE UNIVERSITY · PI CARSON, RICHARD E., VAN DYCK, CHRISTOPHER H · 2017 to 2020
$3.2M
Development of Novel SV2A PET Agents for Early Detection of Alzheimers DiseaseR01AG058773 · NIA · YALE UNIVERSITY · PI CAI, ZHENGXIN · 2018 to 2020
PET imaging of synaptic vesicle glycoprotein 2A (SV2A) has proven to be a powerful research tool for neurologic disorders. Dynamic SV2A PET scans provide data related to cerebral blood flow and SV2A density, which have been shown to be altered in neurologic disorders such as Alzheimer disease. [
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Noninvasive Quantification of [ · full record | OpenQuestion